What is PAH?

Pulmonary arterial hypertension (PAH for short) is a serious condition characterised by high blood pressure in the arteries of the lungs, also known as the pulmonary arteries.

Living well with PAH

PAH can affect all aspects of daily life – from mental health to career decisions. It is important to be informed and have the right support.

Practical Support and Resources

A PAH diagnosis can be daunting, but it is important to remember you are not alone, there are many places to go for support.

Discover the PH Patient Charter

Discover the PH Patient Charter

Inspiring stories from people living with PAH


Hollie, UK

“It’s about mentality not physicality. Don’t let PAH change the course that you want to take.”


Amina, Bosnia and Herzegovina

“To look beyond my PAH diagnosis and help others achieve their goals.”


Liv, Switzerland

“If you really want to do something, try it, but do not fight the disease – embrace it as a part of your life and you can accomplish so much.”


Andjela, Serbia

“I have PAH, but PAH doesn’t have me.”​


Pere, Spain

“I can’t do the same activities as before, but dealing with my PAH diagnosis has helped me to find a new rhythm in life and enjoy life more intensely in every moment.”​


Irena, Bulgaria

“My diagnosis was not a life-sentence. I’ve found my own way to be happy taking care of myself and others.”​


Jana, Czech Republic

“You should focus on what you can do, not what you can’t do.”​


Melinda, Hungary

“It is scary at first, but you need to live your life your own way and never be afraid of what’s next.”​


Nadiya, Ukraine

“The most important thing is to do what brings you and others joy, so do your favourite things and you will find inner happiness.”​

Visit the Living Well with PAH page or Practical Support and Resources page for more information.


National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: prevention and management. 2014. CG178.
APA Clinical Guidelines. American Psychiatric Association. Practice Guidelines for the treatment of patients with schizophrenia. 2004.
Hasan et al. World J Biol Psychiatry 2012; 13: 318─378.
Logo Janssen | Pharmaceutical Companies of Johnson & Johnson